m6A methylation regulators as predictors for treatment of advanced urothelial carcinoma with anti-PDL1 agent

MLA

Jianqiu Kong, et al. “M6A Methylation Regulators as Predictors for Treatment of Advanced Urothelial Carcinoma with Anti-PDL1 Agent.” Frontiers in Immunology, vol. 13, Sept. 2022. EBSCOhost, https://doi.org/10.3389/fimmu.2022.1014861.

APA

Jianqiu Kong, Sihong Lu, Long Zhang, Yuhui Yao, Jie Zhang, Zefeng Shen, Mingli Luo, Bin Liu, Junjiong Zheng, & Tianxin Lin. (2022). m6A methylation regulators as predictors for treatment of advanced urothelial carcinoma with anti-PDL1 agent. Frontiers in Immunology, 13. https://doi.org/10.3389/fimmu.2022.1014861

Chicago

Jianqiu Kong, Sihong Lu, Long Zhang, Yuhui Yao, Jie Zhang, Zefeng Shen, Mingli Luo, Bin Liu, Junjiong Zheng, and Tianxin Lin. 2022. “M6A Methylation Regulators as Predictors for Treatment of Advanced Urothelial Carcinoma with Anti-PDL1 Agent.” Frontiers in Immunology 13 (September). doi:10.3389/fimmu.2022.1014861.